Chairs: R. Riccardi, IT - M.C.G. Stevens, UK - A. Eggert, DE
Co-Chair: B. Morland, UK
Educational Advisor: W. Gatzemeier, IT
ESO and SIOP-Europe are pleased to announce the fifth Masterclass in Paediatric Oncology. This clinically-oriented educational programme has been designed for young paediatric oncologists who wish to improve their skills in clinical management of common childhood tumours. It is designed to offer a unique learning experience, providing practice-oriented training and the teaching sessions will focus on the application of the most recent research findings to clinical practice.
• Qualified training in paediatric oncology to improve their knowledge of the main topics listed below.
• Skills in dealing with cancer problems as a whole
• Knowledge of current clinical practice and state of the art treatment
• Central nervous system tumours
• Soft-tissue sarcoma
• Bone tumours
• Wilms’ tumour
• Rare tumours
The Masterclass in Paediatric Oncology is an ESO-SIOP Europe joint event
|ESO is particularly grateful to the following organisation for his support:|
European School of Oncology - Bellinzona Office
Piazza Indipendenza 2
6500 Bellinzona - Switzerland
Tel: +41 91 820 0954
Fax: +41 91 820 0953
CME ACCREDITATION AND CERTIFICATE
Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS).
EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from the organising secretariat.
Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.
TRAVEL GRANTS - ASSOCIAZIONE CORRERE PER LA SPERANZA
ESO and SIOP-E are grateful to the Italian association: Associazione Correre per la Speranza (www.lacorsadellasperanza.org) for having provided:
• Travel grants to support the participation of Italian paediatric oncologists in the Masterclass.
- The request for a travel grant must be mentioned in the letter accompanying the application, indicating the amount needed to cover travel costs.
- Registration, travel and accommodation costs will be covered by the grant.
The outcome for the grant application will be made known mid-April.
S. Ayme, Orphanet, INSERM US14, Paris, FR
S. Bielack, Olgahospital, Dept. of Oncology, Stuttgart, DE
H.N. Caron, Academic Medical Centre, Emma’s Children Hospital, Amsterdam, NL
F. Doz, Institut Curie, Paediatric Department, Paris, FR
J.C. Dupont, Institut Curie, Paediatric Department, Paris, FR
A. Eggert, Charité - Berlin University, Department of Paediatric Oncology/ Haematology, Berlin, DE
D. Ford, University Hospitals Birmingham NHS Foundation Trust Queen Elizabeth Hospital, Birmingham, UK
J. Grill, Institut Gustave Roussy, Department of Pediatrics, Villejuif, FR
D. Hargrave, Royal Marsden Hospital, Department of Paediatric Oncology, Surrey, UK
L. Hjorth, Skåne University Hospital, Department of Paediatrics, Lund, SE
D. Körholz, Universitätsklinikum, Halle, Halle, DE
B. Morland, Birmingham Childrens’ Hospital, Birmingham, UK
D. Orbach, Institut Curie, Paediatric Department, Paris, FR
A. Peet, Birmingham Children’s Hospital, Birmingham, UK
R. Riccardi, Policlinico Universitario A. Gemelli, Div. of Paediatric Oncology, Roma, IT
D. Schneider, Klinikum Dortmund, Children’s Department, Dortmund, DE
F. Spreafico, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
E. Steliarova-Foucher, International Agency for Research in Cancer, Lyon, FR
M.C.G. Stevens, Royal Hospital for Children, Dept. of Oncology, Bristol, UK
G.Vassal, Institut Gustave Roussy, Department of Pediatric and Clinical Pharmacology, Villejuif, FR
|Welcome from the chairs followed by dinner|
|08:00||Multiple choice pre-test|
Osteosarcoma and Ewing sarcoma: Presentation, diagnostic and therapeutic approaches
Key note lecture Pediatric Cancer Epidemiology and cases
Introduction to rare tumours
|Germ Cell Tumours |
D. Schneider, DE
B. Morland, UK
|State-of-the-Art in neuroblastoma therapy |
H. Caron, NL
On the way to personalized medicine approaches in neuroblastoma diagnostics and treatment
|11:30||Key note lecture Personalised medicines in cancer: |
myth or a reality?
G. Vassal, FR
|Free afternoon in Ljubjana followed by dinner|
SOFT TISSUE SARCOMA
M.C.G. Stevens, UK
Non Rhabdo Soft Tissue Sarcoma
|Questions and discussion |
M.C.G. Stevens, UK - D. Orbach, FR
Key note lecture Early phase studies
|Key note lecture Ethics - case based discussion |
F. Doz, FR - J-C. Dupont, FR
|Overview: Hodgkin's Lymphoma |
D. Körholz, DE
|Key note lecture Radiobiology and radiotherapy techniques D. Ford, UK|
High grade gliomas of the brain and brainstem: towards biology - driven treatment
Low grade gliomas
Key note lecture Survivorship
Key note lecture Problems and solutions in the
|10:30||Multiple choice test|
|11:00||Discussion and closure|